Fotios Barkas/ LinkedIn
Sep 1, 2025, 07:37
Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines
Fotios Barkas, Assistant Professor of Internal Medicine University of Ioannina, shared a noteworthy post on LinkedIn:
“Just released in ESC2025: Updated Dyslipidemia Guidelines
Key highlights:
- CAC Score for risk
- LDL-C cutoffs for LLL initiation
- Bempedoic acid and Evinacumab
- Lp(a) ≥50 mg/dL as a cutoff
- Intensification of LLM post-ACS
- EPA only
- Volanesorsen in FCS, statins in HIV, and anthracyclin-induced cardiotoxicity
- Dietary supplements”
Stay updated with Hemostasis Today.
Bempedoic Acid
CAC Score
Cardiotoxicity
cardiovascular risk
Dietary Supplements
Dyslipidemia Guidelines
EPA
ESC 2025
European Atherosclerosis Society
Evinacumab
Familial Chylomicronemia Syndrome
Health
Hematology
Hemostasis Today
HIV
LDL Cholesterol
Lipid Lowering Therapy
Lipoprotein a
Medicine
Post ACS Management
statins
Volanesorsen
-
Nov 6, 2025, 08:24Jacqui McCallum Reflects on Meeting with The Royal Melbourne Hospital Stroke and Neurology Ward Team
-
Nov 6, 2025, 08:17Maxime Dely: The True Heroes of Blood Donation Are Them!
-
Nov 6, 2025, 07:11Francesco Giurazza on Radial Access for Liver Transarterial Chemoembolization
-
Nov 6, 2025, 07:04Andrea Van Beek: Proud to be a Certified Anticoagulation Care Provider (CACP)!
-
Nov 6, 2025, 06:57Jian-Ke Tie’s Team on Comorbidity of VitK-dependent Clotting Factors Deficiency and Chondrodysplasia Punctata
-
Nov 6, 2025, 04:17Aakanksha A To Present Insights from ASH Education Social Media Initiative at 67th ASH Meeting
-
Nov 6, 2025, 04:03Yaping Zhang on Two-Way GPIb-IX Signaling in Platelet Activation and VWF Binding
-
Nov 6, 2025, 03:38Thierry Burnouf on Platelet-Derived Extracellular Vesicles and Their Role in Neurogenesis
-
Nov 6, 2025, 03:29Shubham Misra to Present 3 Abstracts at International Stroke Conference 2026
Nov 6, 2025, 08:17
Nov 5, 2025, 10:45
Nov 5, 2025, 10:43